Literature DB >> 2953511

Eosinophils of human colonic mucosa: C3b and Fc gamma receptor expression and phagocytic capabilities.

W L Beeken, I Northwood, C Beliveau, G Baigent, D Gump.   

Abstract

Because little is known about eosinophils of the human intestine, we measured their C3b and Fc gamma receptor expression and phagocytic activity in mucosal suspensions from colon resections for large bowel neoplasms. Enzymatically dissociated suspensions were enriched for eosinophils by countercurrent centrifugation. C3b and Fc gamma receptors were measured by immunofluorescent assays with flow cytometry. Phagocytosis of Escherichia coli ON2 was determined by an in vitro microscopic method. Suspensions of normal tissue from neoplasm resections yielded 1.8 X 10(6) eosinophils/g mucosa, and these cells were more numerous than either macrophages or neutrophils. Fivefold enrichment was achieved by countercurrent centrifugation, and 75% of these cells expressed C3b receptors and 90% expressed Fc gamma receptors. Sixty-seven percent of mucosal eosinophils were phagocytic for E. coli ON2 and ingested a mean of 4.7 bacteria per cell. Eosinophils accounted for more overall phagocytic activity than either neutrophils or macrophages.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2953511     DOI: 10.1016/0090-1229(87)90138-3

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  3 in total

1.  Helminthotoxic responses of intestinal eosinophils to Trichinella spiralis newborn larvae.

Authors:  T D Lee
Journal:  Infect Immun       Date:  1991-12       Impact factor: 3.441

2.  Eosinophil activation in ulcerative colitis: studies on mucosal release and localization of eosinophil granule constituents.

Authors:  Y Raab; K Fredens; B Gerdin; R Hällgren
Journal:  Dig Dis Sci       Date:  1998-05       Impact factor: 3.199

3.  Effects of proteoglycan on dextran sulfate sodium-induced experimental colitis in rats.

Authors:  Sakae Ota; Shuichi Yoshihara; Keinosuke Ishido; Masanori Tanaka; Keiichi Takagaki; Mutsuo Sasaki
Journal:  Dig Dis Sci       Date:  2008-05-08       Impact factor: 3.199

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.